MarketCap
Facebook
X
Telegram
Tiziana Life Sciences PLC Balance Sheet 2024-2011 | TLSA
Brief overview of Tiziana Life Sciences PLC's balance sheet strength
The balance sheet is assessed across five available annual reports spanning 2020 to 2024.
Across five reporting periods, assets decreased -84%, from $70.7 million to $11.3 million, producing a negative trend.
Liabilities expanded faster than the asset base, -11.1% versus -84%. Debt-service capacity deserves attention.
Equity represents 34.9% of assets versus 88.3% initially. The capital structure appears balanced.
Cash accounts for 33% of assets versus 93.2% initially. The change indicates the degree of financial flexibility.
Retained earnings remain negative at -$144.8 million. This may reflect past losses or substantial shareholder distributions, so earnings and buybacks provide important context.
Overall picture
Tiziana Life Sciences PLC's balance sheet looks stretched: reliance on liabilities and a limited capital cushion increase sensitivity to weaker results.
Annual Balance Sheet Tiziana Life Sciences PLC
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | -936 K | -17.8 M | - | - | - | -3.94 M | 186 K | -4.48 M | -8.69 M | -2.06 M | 169 K | -4 K | -33 K |
Long Term Debt |
- | 109 K | 243 K | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
106 K | 138 K | 122 K | - | 265 K | 279 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 290 K | 411 K | - | - | - | - | - | - | - | - |
Total Liabilities |
7.35 M | 6.65 M | 6.91 M | 7.55 M | 8.27 M | 7.89 M | 6.4 M | 3.51 M | 1.74 M | 746 K | 683 K | 272 K | 136 K | 100 K |
Retained Earnings |
-145 M | -134 M | -116 M | - | -84.6 M | -43.1 M | -39.9 M | -29.8 M | 11 M | -12.2 M | -3.59 M | -21.4 M | -21.1 M | -20.5 M |
Total Assets |
11.3 M | 12.2 M | 26.5 M | 48.8 M | 70.7 M | 2.38 M | 6.92 M | 1.83 M | 5.05 M | 9.25 M | 2.46 M | 126 K | 96 K | 625 K |
Cash and Cash Equivalents |
3.72 M | 1.18 M | 18.1 M | 42.2 M | 65.8 M | 200 K | 5.3 M | 64 K | 5.8 M | - | - | - | - | - |
Book Value |
3.94 M | 5.54 M | 19.6 M | 41.3 M | 62.4 M | -5.51 M | 519 K | -1.68 M | 3.31 M | 8.5 M | 1.78 M | -146 K | -40 K | 525 K |
Total Shareholders Equity |
3.94 M | 5.54 M | 19.6 M | - | 62.4 M | -5.51 M | 519 K | -2.28 M | 4.09 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Tiziana Life Sciences PLC
| 2024-Q4 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 109 K | - | - | - | - | - | - | - | - | 290 K | - | - | - | 541 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
7.35 M | 6.65 M | - | - | - | - | 7.55 M | - | - | - | 8.27 M | - | - | - | 7.89 M | - | - | - | 6.4 M | - | - | - | 4.75 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-145 M | -134 M | - | - | - | - | -108 M | - | - | - | -84.6 M | - | - | - | -60 M | - | - | - | -50.7 M | - | - | - | -42.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
11.3 M | 12.2 M | - | - | - | - | 48.8 M | - | - | - | 70.7 M | - | - | - | 2.38 M | - | - | - | 6.92 M | - | - | - | 2.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
3.72 M | 1.18 M | - | - | - | - | 42.2 M | - | - | - | 65.8 M | - | - | - | 200 K | - | - | - | 5.3 M | - | - | - | 64 K | - | - | - | 5.8 M | - | - | - | 13.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
3.94 M | 5.54 M | - | - | - | - | 41.3 M | - | - | - | 62.4 M | - | - | - | -5.51 M | - | - | - | 519 K | - | - | - | -2.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
3.94 M | 5.54 M | - | - | - | - | 41.3 M | - | - | - | 62.4 M | - | - | - | 69.6 M | - | - | - | 75.8 M | - | - | - | -2.28 M | - | - | - | 4.09 M | - | - | - | 12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Tiziana Life Sciences PLC, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Canada
China
Britain
France
Israel
Germany
Russia
Belgium
Cayman-islands
